Literature DB >> 11333372

Absolute quantification by positron emission tomography of the endogenous ligand.

J Delforge1, M Bottlaender, S Pappata, C Loc'h, A Syrota.   

Abstract

The results of several recent papers have shown a significant influence of the endogenous neurotransmitters on the exogenous ligand kinetics measured by positron emission tomography. For example, several groups found that the percentage of D2 receptor sites occupied by the endogenous dopamine ranged from 25% to 40% at basal level. An obvious consequence of this significant occupancy is that the ligand-receptor model parameters, usually estimated by a model that does not take into account the endogenous ligand (EL) kinetics, can be significantly biased. In the current work, the authors studied the biases obtained by using the multiinjection approach. The results showed that in the classical ligand-receptor model, the receptor concentration is correctly estimated and that only the apparent affinity is biased by not taking the EL into account. At present, all absolute quantifications of the EL have been obtained through pharmacologic manipulation of the endogenous transmitter concentration, which is often too invasive a method to be used in patients. A theoretical reasoning showed that a noninvasive approach is necessarily based on both the apparent affinity measurement and on a multiregion approach. The correlation between the receptor concentration and the apparent affinity, previously observed with some ligands, verifies these two conditions; thus, the authors suggest that this correlation could be the result of the EL effect. To test this assumption experimentally, the effect of reserpine-induced dopamine depletion on the interactions between the D2 receptor sites and the FLB 457 is studied. With untreated baboons, the apparent FLB 457 affinity was smaller in the receptor-rich regions (striatum) than in the receptor-poor regions. This discrepancy disappeared after dopamine depletion, strongly suggesting that this affinity difference was related to the EL effect. Therefore, the purpose of the current study was to test the ability to quantify the EL based on the observed correlation between the receptor concentration and the apparent affinity. This approach offers a method for estimating the percentage of receptor sites occupied by the EL and, if its affinity is known, the free EL concentration. From the data obtained using FLB 457 with baboons, the authors found that approximately 53% of the D2 receptor sites are occupied by dopamine in the striatum and that the free dopamine concentration is approximately 120 nmol/L at basal level. This approach is transferable to patients, because the experimental data are obtained without pharmacologically induced modification of the EL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333372     DOI: 10.1097/00004647-200105000-00016

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

2.  The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.

Authors:  Sargo Aalto; Jussi Hirvonen; Valtteri Kaasinen; Nora Hagelberg; Jaana Kajander; Kjell Någren; Timo Seppälä; Juha O Rinne; Harry Scheinin; Jarmo Hietala
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

3.  Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens.

Authors:  Catarina A Owesson-White; Mitchell F Roitman; Leslie A Sombers; Anna M Belle; Richard B Keithley; Jessica L Peele; Regina M Carelli; R Mark Wightman
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

4.  Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging.

Authors:  Wynne K Schiffer; David L Alexoff; Colleen Shea; Jean Logan; Stephen L Dewey
Journal:  J Neurosci Methods       Date:  2004-12-08       Impact factor: 2.390

5.  5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Dana L Tudorascu; Elizabeth O Ahlers; Maxim S Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  Neuroimage       Date:  2013-03-26       Impact factor: 6.556

6.  Microfabricated Microelectrode Sensor for Measuring Background and Slowly Changing Dopamine Concentrations.

Authors:  Adam K Dengler; Gregory S McCarty
Journal:  J Electroanal Chem (Lausanne)       Date:  2013-02-04       Impact factor: 4.464

7.  In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.

Authors:  Michel Bottlaender; Héric Valette; Jacques Delforge; Wadad Saba; Ilonka Guenther; Olivier Curet; Pascal George; Frédéric Dollé; Marie-Claude Grégoire
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-18       Impact factor: 6.200

8.  High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Authors:  Nicholas T Vandehey; Jeffrey M Moirano; Alexander K Converse; James E Holden; Jogesh Mukherjee; Dhanabalan Murali; R Jerry Nickles; Richard J Davidson; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-30       Impact factor: 6.200

9.  A receptor-based model for dopamine-induced fMRI signal.

Authors:  Joseph B Mandeville; Christin Y M Sander; Bruce G Jenkins; Jacob M Hooker; Ciprian Catana; Wim Vanduffel; Nathaniel M Alpert; Bruce R Rosen; Marc D Normandin
Journal:  Neuroimage       Date:  2013-03-01       Impact factor: 6.556

10.  In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Authors:  Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Ningning Guo; Yasuhiko Sudo; Raj Narendran; Peter Talbot; Marc Laruelle
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.